Acquiring Company
PAI Pharma
Acquired Company
Nivagen Pharmaceuticals
GreenvilleSan FranciscoManufacturingBiotechnologyPharmaceuticalHealthcareSoftwareHealth CareDescription
PAI Pharma has announced the acquisition of Nivagen Pharmaceuticals, enhancing its capabilities in domestic sterile injectable manufacturing. This acquisition supports PAI's strategy to address U.S. healthcare drug shortages and expand its ready-to-use injectable product offerings. Nivagen's advanced aseptic manufacturing infrastructure will strengthen PAI's supply chain resilience and growth initiatives.
Quick answer
PAI Pharma is acquiring Nivagen Pharmaceuticals, announced January 6, 2026. PAI Pharma is based in Greenville, South Carolina, United States.
- How much did PAI Pharma pay for Nivagen Pharmaceuticals?
- The deal value was not disclosed.
- What does PAI Pharma do?
- PAI Pharma is a U.S.-based pharmaceutical manufacturer specializing in oral liquid generic prescription medications, with a strong domestic manufacturing footprint and a commitment to quality, affordability, and supply..
- Where are PAI Pharma and Nivagen Pharmaceuticals based?
- PAI Pharma is based in Greenville, South Carolina, United States. Nivagen Pharmaceuticals is based in San Francisco, California, United States.
- Who are the decision-makers at PAI Pharma?
- Fundz holds 2 contacts at PAI Pharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Healthcare
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie to acquire Revolution Medicines soon (January 9, 2026)
- Danaher acquires Masimo for $9.9 billion, $9.9B (February 18, 2026)
- Torrent Pharma to merge with JB Chemicals soon (February 20, 2026)
- Scinai acquires Recipharm Israel Ltd. (February 17, 2026)
- Alkem Laboratories acquires majority stake in Occlutech (February 16, 2026)
- Halozyme acquires Surf Bio for $300 million, $300M (January 28, 2026)
Who to call at PAI Pharma, and when
When PAI Pharma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day PAI Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PAI Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PAI Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PAI Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Nivagen Pharmaceuticals?
Nivagen Pharmaceuticals was acquired by PAI Pharma, based in Greenville. The deal was reported on January 6, 2026. PAI Pharma is privately held and operates in Manufacturing.
When did PAI Pharma acquire Nivagen Pharmaceuticals?
PAI Pharma's acquisition of Nivagen Pharmaceuticals was reported on January 6, 2026. PAI Pharma has announced the acquisition of Nivagen Pharmaceuticals, enhancing its capabilities in domestic sterile injectable manufacturing. This acquisition supports PAI's strategy to address U.S. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Nivagen Pharmaceuticals do?
Nivagen Pharmaceuticals, Inc. It is privately held, operating in Healthcare, and is based in San Francisco.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.